Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Kearns

Showing results (91-100 of 114) with videos related to

Pageof 12
Sort By:
International Journal of Geriatric Psychiatry|July 16, 2009
Longitudinal investigation of wandering behavior in Department of Veterans Affairs nursing home care unitsBellinda King-Kallimanis, Lawrence Schonfeld, Victor A Molinari, et al.
Nature Immunology|October 23, 2012
Control of RelB during dendritic cell activation integrates canonical and noncanonical NF-κB pathwaysVincent F-S Shih, Jeremy Davis-Turak, Monica Macal, et al.
Human Molecular Genetics|July 29, 2022
Opposing effects of genetic variation in MTCH2 for obesity versus heart failureJulie A Fischer, Tanner O Monroe, Lorenzo L Pesce, et al.
Transplant Immunology|September 10, 2021
BLyS neutralization results in selective anti-HLA alloantibody depletion without successful desensitizationDivyansh Agarwal, Eline T Luning Prak, Tina Bharani, et al.
Investigational New Drugs|November 18, 2016
A phase 1 study combining the HER3 antibody seribantumab (MM-121) and cetuximab with and without irinotecanJames M Cleary, Autumn J McRee, Geoffrey I Shapiro, et al.
Science Translational Medicine|February 5, 2016
MM-151 overcomes acquired resistance to cetuximab and panitumumab in colorectal cancers harboring EGFR extracellular domain mutationsSabrina Arena, Giulia Siravegna, Benedetta Mussolin, et al.
Biosecurity and Bioterrorism : Biodefense Strategy, Practice, and Science|February 18, 2014
Hospital bioterrorism planning and burn surgeRandy D Kearns, Brent Myers, Charles B Cairns, et al.
Molecular Cancer Therapeutics|April 26, 2015
Enhanced Targeting of the EGFR Network with MM-151, an Oligoclonal Anti-EGFR Antibody TherapeuticJeffrey D Kearns, Raghida Bukhalid, Mark Sevecka, et al.
American Journal of Disaster Medicine|October 29, 2014
Deployable, portable, and temporary hospitals; one state's experiences through the yearsRandy D Kearns, Mary Beth Skarote, Jeff Peterson, et al.
North Carolina Medical Journal|October 29, 2015
North Carolina College of Emergency Physicians' Guidance Document on Emergency Medical ServicesJames E Winslow, Antonio R Fernandez, Doug Swanson, et al.
Pageof 12

Showing results (91-100 of 114) with videos related to

Sort By:
Pageof 12
International Journal of Geriatric Psychiatry|July 16, 2009
Longitudinal investigation of wandering behavior in Department of Veterans Affairs nursing home care unitsBellinda King-Kallimanis, Lawrence Schonfeld, Victor A Molinari, et al.
Nature Immunology|October 23, 2012
Control of RelB during dendritic cell activation integrates canonical and noncanonical NF-κB pathwaysVincent F-S Shih, Jeremy Davis-Turak, Monica Macal, et al.
Human Molecular Genetics|July 29, 2022
Opposing effects of genetic variation in MTCH2 for obesity versus heart failureJulie A Fischer, Tanner O Monroe, Lorenzo L Pesce, et al.
Transplant Immunology|September 10, 2021
BLyS neutralization results in selective anti-HLA alloantibody depletion without successful desensitizationDivyansh Agarwal, Eline T Luning Prak, Tina Bharani, et al.
Investigational New Drugs|November 18, 2016
A phase 1 study combining the HER3 antibody seribantumab (MM-121) and cetuximab with and without irinotecanJames M Cleary, Autumn J McRee, Geoffrey I Shapiro, et al.
Science Translational Medicine|February 5, 2016
MM-151 overcomes acquired resistance to cetuximab and panitumumab in colorectal cancers harboring EGFR extracellular domain mutationsSabrina Arena, Giulia Siravegna, Benedetta Mussolin, et al.
Biosecurity and Bioterrorism : Biodefense Strategy, Practice, and Science|February 18, 2014
Hospital bioterrorism planning and burn surgeRandy D Kearns, Brent Myers, Charles B Cairns, et al.
Molecular Cancer Therapeutics|April 26, 2015
Enhanced Targeting of the EGFR Network with MM-151, an Oligoclonal Anti-EGFR Antibody TherapeuticJeffrey D Kearns, Raghida Bukhalid, Mark Sevecka, et al.
American Journal of Disaster Medicine|October 29, 2014
Deployable, portable, and temporary hospitals; one state's experiences through the yearsRandy D Kearns, Mary Beth Skarote, Jeff Peterson, et al.
North Carolina Medical Journal|October 29, 2015
North Carolina College of Emergency Physicians' Guidance Document on Emergency Medical ServicesJames E Winslow, Antonio R Fernandez, Doug Swanson, et al.
Pageof 12